Recent Advances in Targetable Therapeutics in Metastatic Non-Squamous NSCLC

Lung adenocarcinoma is the most common subtype of non-small cell lung cancer (NSCLC). With the discovery of epidermal growth factor receptor (EGFR) mutations, anaplastic lymphoma kinase (ALK) rearrangements, and effective targeted therapies, therapeutic options are expanding for patients with lung a...

Descripción completa

Detalles Bibliográficos
Autores principales: Bansal, Pranshu, Osman, Diaa, Gan, Gregory N., Simon, George R., Boumber, Yanis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854869/
https://www.ncbi.nlm.nih.gov/pubmed/27200298
http://dx.doi.org/10.3389/fonc.2016.00112

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854869/
https://www.ncbi.nlm.nih.gov/pubmed/27200298
http://dx.doi.org/10.3389/fonc.2016.00112

Ejemplares similares